124 related articles for article (PubMed ID: 18369300)
1. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain.
Puig-Tintoré LM; Castellsagué X; Torné A; de Sanjosé S; Cortés J; Roura E; Méndez C; Bosch FX
J Low Genit Tract Dis; 2008 Apr; 12(2):82-9. PubMed ID: 18369300
[TBL] [Abstract][Full Text] [Related]
2. Current techniques in screening for cervical cancer in Spain: updated recommendations.
Puig-Tintoré LM; Torné A; Alonso I
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
[TBL] [Abstract][Full Text] [Related]
3. Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey.
de Sanjose S; Cortés X; Méndez C; Puig-Tintore L; Torné A; Roura E; Bosch FX; Castellsague X
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):234-40. PubMed ID: 18499332
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
5. Use of the Pap test by a population group in Buenos Aires.
Klimovsky E; Matos E
Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
[TBL] [Abstract][Full Text] [Related]
6. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
Massad LS; Verhulst SJ; Hagemeyer M; Brady P
J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
[TBL] [Abstract][Full Text] [Related]
7. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
[TBL] [Abstract][Full Text] [Related]
8. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of epithelial squamous cell abnormalities and associated factors in women of a rural town of Colombia].
Grisales H; Vanegas AP; Gaviria AM; Castaño J; Mora MA; Borrero M; Rojas C; Arbeláez MP; Sánchez GI
Biomedica; 2008 Jun; 28(2):271-83. PubMed ID: 18719718
[TBL] [Abstract][Full Text] [Related]
11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Alves C; Alves L; Lunet N
Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
[TBL] [Abstract][Full Text] [Related]
14. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening: knowledge of own screening status among women aged 20-29 years.
Munk C; Kjaer SK; Poll P; Bock JE
Acta Obstet Gynecol Scand; 1998 Oct; 77(9):917-22. PubMed ID: 9808380
[TBL] [Abstract][Full Text] [Related]
16. Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003.
van der Aa MA; Siesling S; Louwman MW; Visser O; Pukkala E; Coebergh JW
Eur J Cancer Prev; 2008 Oct; 17(5):453-9. PubMed ID: 18714188
[TBL] [Abstract][Full Text] [Related]
17. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
[TBL] [Abstract][Full Text] [Related]
18. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
19. [Cervical cancer of the uterus. Analytic epidemiology].
Gimeno Ortiz A; Jiménez Romano R; Camps Pérez del Bosque JR
Rev Sanid Hig Publica (Madr); 1993; 67(3):217-25. PubMed ID: 7732287
[TBL] [Abstract][Full Text] [Related]
20. Social support and cervical and breast cancer screening in Argentinean women from a rural population.
Gamarra CJ; Paz EP; Griep RH
Public Health Nurs; 2009; 26(3):269-76. PubMed ID: 19386062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
